Conditions: Epilepsy
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 376
Healthy volunteers: no

Brief summary:
The main purpose of this trial is to determine safety and efficacy of Lacosamide under long term therapy.

Detailed description:

Arms:
arm 1: 50 mg and 100 mg tablets up to 800 mg/day as twice day (BID) dosing

Interventions: intervention 1: Lacosamide
Intervention descriptions: intervention 1: 50 mg and 100 mg tablets up to 800 mg/day as twice day (BID) dosing throughout the trial

Protocol document: